NovaBridge Biosciences
NBP- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001778016
In the last 90 days, NovaBridge Biosciences insiders filed 0 open-market purchases and 4 sales; 49 institutions reported holding it in 13F filings for Q2 2026, worth $48.1M in total; HHLR Advisors (Hillhouse) is the only superinvestor holding it.
13F holders, Q1 2024
Institutional positions in NovaBridge Biosciences as of Mar 31, 2024. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 39
- −5 vs. Q4 2023
- Shares held
- 12.2M
- −148.8K (−1.2%) vs. Q4 2023
- Total value
- $22.7M
- −$767.8K (−3.3%) vs. Q4 2023
- New holders
- 6
- 11 more added
- Sold out
- 11
- 9 more reduced
Compare with Q4 2023: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting NBP on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 49 | $48.1M |
| Q1 2026 | 48 | $72.1M |
| Q4 2025 | 57 | $132.1M |
| Q3 2025 | 42 | $112.3M |
| Q2 2025 | 32 | $22.7M |
| Q1 2025 | 29 | $7.41M |
| Q4 2024 | 28 | $10.1M |
| Q3 2024 | 28 | $17.6M |
| Q2 2024 | 38 | $25.3M |
| Q1 2024 | 39 | $22.7M |
| Q4 2023 | 44 | $23.5M |
| Q3 2023 | 47 | $20.1M |
| Q2 2023 | 48 | $55.9M |
| Q1 2023 | 53 | $71.6M |
| Q4 2022 | 69 | $103.9M |
| Q3 2022 | 75 | $123.3M |
| Q2 2022 | 97 | $430.3M |
| Q1 2022 | 120 | $654.5M |
| Q4 2021 | 132 | $1.85B |
| Q3 2021 | 145 | $2.61B |
| Q2 2021 | 136 | $2.38B |
| Q1 2021 | 80 | $1.13B |
Institutions, Q1 2024
Shares, value and share of portfolio for each institution holding NovaBridge Biosciences; share changes are against Q4 2023.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| HHLR Advisors, Ltd.SuperinvestorHHLR Advisors (Hillhouse) | 6,909,220 | $12.9M | 0.28% | 00.0% | Unchanged |
| Caligan Partners LP | 756,538 | $1.41M | 0.37% | +756,538 | New |
| Two Sigma Advisers, LP | 617,100 | $1.15M | 0.00% | +58,400+10.5% | Added |
| Two Sigma Investments, LP | 575,580 | $1.07M | 0.00% | +679+0.1% | Added |
| Temasek Holdings (Private) Ltd | 566,650 | $1.05M | 0.01% | 00.0% | Unchanged |
| Gsa Capital Partners LLP | 432,621 | $805.0K | 0.06% | −105,498−19.6% | Reduced |
| Boothbay Fund Management, LLC | 378,269 | $703.6K | 0.02% | +378,269 | New |
| Exome Asset Management LLC | 325,762 | $605.9K | 0.52% | +325,762 | New |
| EDBI Pte Ltd | 222,136 | $413.2K | 0.46% | 00.0% | Unchanged |
| Standard Life Aberdeen plc | 162,580 | $302.4K | 0.00% | 00.0% | Unchanged |
| Catalyst Funds Management Pty Ltd | 146,290 | $272.1K | 0.08% | +146,290 | New |
| Man Group plc | 134,977 | $251.1K | 0.00% | +24,353+22.0% | Added |
| State Street Corp | 110,373 | $205.3K | 0.00% | +8,674+8.5% | Added |
| Millennium Management LLC | 93,508 | $173.9K | 0.00% | −97,793−51.1% | Reduced |
| Invesco Ltd. | 85,144 | $158.4K | 0.00% | +65,381+330.8% | Added |
| Goldman Sachs Group Inc | 84,941 | $158.0K | 0.00% | −60,254−41.5% | Reduced |
| Prelude Capital Management, LLC | 81,262 | $151.1K | 0.01% | +47,712+142.2% | Added |
| Alberta Investment Management Corp | 74,723 | $139.0K | 0.00% | 00.0% | Unchanged |
| Marshall Wace, LLP | 71,088 | $132.2K | 0.00% | +71,088 | New |
| Renaissance Technologies LLC | 63,800 | $119.0K | 0.00% | 00.0% | Unchanged |
| Dimensional Fund Advisors LP | 60,407 | $112.4K | 0.00% | +24,284+67.2% | Added |
| Barclays PLC | 38,552 | $71.7K | 0.00% | −134,512−77.7% | Reduced |
| Geode Capital Management, LLC | 34,347 | $63.9K | 0.00% | 00.0% | Unchanged |
| Mariner, LLC | 31,535 | $58.7K | 0.00% | +17,937+131.9% | Added |
| XTX Topco Ltd | 30,485 | $56.7K | 0.01% | −5,466−15.2% | Reduced |
| Donald L. Hagan, LLC | 30,000 | $55.8K | 0.03% | 00.0% | Unchanged |
| Atom Investors LP | 29,612 | $55.1K | 0.01% | +29,612 | New |
| Bank of America Corp | 18,857 | $35.1K | 0.00% | −23,574−55.6% | Reduced |
| Morgan Stanley | 10,109 | $18.8K | 0.00% | −506,587−98.0% | Reduced |
| BlackRock Inc. | 7,923 | $14.7K | 0.00% | −92,142−92.1% | Reduced |
| Qube Research & Technologies Ltd | 4,065 | $7.56K | 0.00% | +1,897+87.5% | Added |
| Royal Bank of Canada | 1,644 | $3.00K | 0.00% | 00.0% | Unchanged |
| Rhumbline Advisers | 1,371 | $2.55K | 0.00% | 00.0% | Unchanged |
| UBS Group AG | 1,331 | $2.48K | 0.00% | −13,948−91.3% | Reduced |
| Legal & General Group Plc | 1,191 | $2.22K | 0.00% | 00.0% | Unchanged |
| Frazier Financial Advisors, LLC | 375 | $698 | 0.00% | +75+25.0% | Added |
| GAMMA Investing LLC | 63 | $117 | 0.00% | 00.0% | Unchanged |
| Citigroup Inc | 50 | $93 | 0.00% | 00.0% | Unchanged |
| Simplex Trading, LLC | 84 | $0 | 0.00% | +80+2,000.0% | Added |
| Canada Pension Plan Investment Board | 0 | $0 | 0.00% | −313,600−100.0% | Sold out |
| Schroder Investment Management Group | 0 | $0 | 0.00% | −310,499−100.0% | Sold out |
| Acadian Asset Management LLC | 0 | $0 | 0.00% | −155,572−100.0% | Sold out |
| Diametric Capital, LP | 0 | $0 | 0.00% | −99,295−100.0% | Sold out |
| Citadel Advisors LLC | 0 | $0 | 0.00% | −74,029−100.0% | Sold out |
| Susquehanna International Group, LLP | 0 | $0 | 0.00% | −29,365−100.0% | Sold out |
| Tower Research Capital LLC (TRC) | 0 | $0 | 0.00% | −24,608−100.0% | Sold out |
| Nomura Holdings Inc | 0 | $0 | 0.00% | −23,000−100.0% | Sold out |
| HRT Financial LP | 0 | $0 | 0.00% | −17,354−100.0% | Sold out |
| Two Sigma Securities, LLC | 0 | $0 | 0.00% | −11,073−100.0% | Sold out |
| Headlands Technologies LLC | 0 | $0 | 0.00% | −7,698−100.0% | Sold out |